Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1406 vs Humira in Ankylosing Spondylitis
NCT04135508Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Dec 2016
- Primary completion
- Mar 2018
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of qletli in ankylosing spondylitis (AS), sponsored by Bio-Thera Solutions, Ltd.. Started Dec 2016; status: completed.
02
Drugs
qletli
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT04135508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135508.